|
|
||||||||
From the Cole Eye Institute, Cleveland Clinic Foundation, Cleveland Ohio.
PURPOSE. To identify the molecular mechanism of steroid-induced downregulation of vascular endothelial growth factor (VEGF) synthesis in Müller cells.
METHODS. Confluent cultures of human Müller cells (MIO-M1) were treated with 100 µM CoCl2, 1 µg/mL triamcinolone acetonide (TA), or both. VEGF secretion was measured with respect to time by ELISA. VEGF mRNA quantity and stability were analyzed by reverse transcriptasepolymerase chain reaction. The activity of hypoxia-inducible factor (HIF)-1 was measured by the relative binding of HIF-1 protein to the hypoxia response element (HRE), by gel shift and ELISA. The HIF-1
protein level was determined with Western blot.
RESULTS. TA decreased VEGF secretion by at least 50% in the presence of continuous cobalt stimulus. VEGF mRNA decreased 50- to 100-fold 6 hours after treatment with TA and cobalt compared with cobalt alone. VEGF mRNA stability was decreased in cobalt-stimulated, TA-treated cells compared with cobalt alone in cells synchronized by exposure to actinomycin D. HIF-1
protein level was sustained for the entire 24-hour treatment period and partitioned into nuclear, not cytosolic, fractions. HIF-1 activity was decreased by 20% to 30% in the presence of TA and cobalt compared with cobalt alone.
CONCLUSIONS. TA may decrease VEGF synthesis by nongenomic destabilization of VEGF mRNA in cobalt-stimulated Müller cells. There was little effect on the total HIF-1
protein level, HIF-1 partitioning, and HIF-1 activity.
This article has been cited by other articles:
![]() |
M. Hollborn, C. Stathopoulos, A. Steffen, P. Wiedemann, L. Kohen, and A. Bringmann Positive Feedback Regulation between MMP-9 and VEGF in Human RPE Cells Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4360 - 4367. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mizuno, A. Nishiwaki, H. Morita, T. Miyake, and Y. Ogura Effects of Periocular Administration of Triamcinolone Acetonide on Leukocyte-Endothelium Interactions in the Ischemic Retina Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2831 - 2836. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ebrahem, A. Minamoto, G. Hoppe, B. Anand-Apte, and J. E. Sears Triamcinolone Acetonide Inhibits IL-6- and VEGF-Induced Angiogenesis Downstream of the IL-6 and VEGF Receptors Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4935 - 4941. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hartnett, D. J. Martiniuk, Y. Saito, P. Geisen, L. J. Peterson, and J. R. McColm Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced Retinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4975 - 4982. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |